{"nct_id":"NCT02545075","title":"A Comparative Study in Chinese Subjects With Chemotherapy Naïve Stage IV Melanoma Receiving Ipilimumab (3 mg/kg) vs. Dacarbazine","status":"COMPLETED","status_verified_date":"2020-05","start_date":"2015-10-31","start_date_type":"ACTUAL","primary_completion_date":"2019-04-19","primary_completion_date_type":"ACTUAL","completion_date":"2019-04-19","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BMY"]}